跳至主要内容
临床试验/NCT02137031
NCT02137031已完成不适用

Continuous Glucose Monitoring and HbA1c in Children for Longterm Diabetes Management

University of Toronto4 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2012年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
4
主要终点
HbA1c

研究概览

简要总结

The primary purpose of this pilot randomized controlled trial is to provide preliminary indicators of the effects of continuous subcutaneous insulin infusion with continuous glucose monitoring compared to self-monitoring of blood glucose alone on: (1) metabolic control and (2) fear of hypoglycemia. Additional objectives will be: (1) to provide an estimate of recruitment rates, (2) to assess compliance with allocated treatment, and (3) to determine participants' satisfaction with allocated treatment.

With increased and immediate information related to current and future (trend) glucose information provided by the continuous glucose monitor, children can then act upon this knowledge to prevent hypo- or hyperglycemia, thus, experiencing a reduction in glucose variability, leading to an improvement in metabolic control as shown by a reduction in HbA1c levels.

Research on the effectiveness of continuous glucose monitoring on metabolic control in children with T1D using continuous subcutaneous insulin infusion has been limited. Therefore, a pilot clinical trial will be designed to provide preliminary indicators of the feasibility and acceptability of continuous glucose monitoring on metabolic control and address the following objectives.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
6 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children aged 6-18 years
  • T1D for greater than one year;
  • Willing to perform at least three self-monitoring blood glucose tests per day;
  • Has been using continuous subcutaneous insulin infusion for more than one month
  • English speaking

排除标准

  • Presence of celiac disease (can cause malabsorption of nutrients affecting metabolic control)
  • Use of corticosteroids that have systemic effects and affect glucose levels
  • Currently using continuous glucose monitoring
  • Cognitively unable to self-manage, based on parent's and/or care provider's opinion

结局指标

主要结局

HbA1c

时间窗: 3 months

Metabolic control as measured by standard HbA1c

次要结局

  • Fear of Hypoglycemia(3 months)
  • Frequency of Hypoglycemia(3 months)
  • Frequency of Hyperglycemia(3 months)
  • Frequency of Diabetic Ketoacidosis(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Krystie Robinson-Vincent

PhD Candidate

University of Toronto

研究点 (4)

Loading locations...

相似试验